Logo image of NBHC

NATIONAL BANK HOLD-CL A (NBHC) Stock Fundamental Analysis

NYSE:NBHC - New York Stock Exchange, Inc. - US6337071046 - Common Stock - Currency: USD

40.02  -0.16 (-0.4%)

After market: 40.02 0 (0%)

Fundamental Rating

3

Taking everything into account, NBHC scores 3 out of 10 in our fundamental rating. NBHC was compared to 394 industry peers in the Banks industry. NBHC has a bad profitability rating. Also its financial health evaluation is rather negative. NBHC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NBHC was profitable.
In the past year NBHC had a positive cash flow from operations.
NBHC had positive earnings in each of the past 5 years.
Of the past 5 years NBHC 4 years had a positive operating cash flow.
NBHC Yearly Net Income VS EBIT VS OCF VS FCFNBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

NBHC has a better Return On Assets (1.10%) than 73.86% of its industry peers.
NBHC has a Return On Equity (8.37%) which is in line with its industry peers.
Industry RankSector Rank
ROA 1.1%
ROE 8.37%
ROIC N/A
ROA(3y)1.13%
ROA(5y)1.2%
ROE(3y)9.09%
ROE(5y)9.84%
ROIC(3y)N/A
ROIC(5y)N/A
NBHC Yearly ROA, ROE, ROICNBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

NBHC has a better Profit Margin (27.33%) than 72.59% of its industry peers.
In the last couple of years the Profit Margin of NBHC has remained more or less at the same level.
The Operating Margin and Gross Margin are not available for NBHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 27.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-2.49%
PM growth 5Y0.93%
GM growth 3YN/A
GM growth 5YN/A
NBHC Yearly Profit, Operating, Gross MarginsNBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

NBHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
NBHC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NBHC has been increased compared to 5 years ago.
NBHC has a worse debt/assets ratio than last year.
NBHC Yearly Shares OutstandingNBHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NBHC Yearly Total Debt VS Total AssetsNBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

The Debt to FCF ratio of NBHC is 0.60, which is an excellent value as it means it would take NBHC, only 0.60 years of fcf income to pay off all of its debts.
NBHC's Debt to FCF ratio of 0.60 is amongst the best of the industry. NBHC outperforms 81.47% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that NBHC is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.06, NBHC is doing good in the industry, outperforming 79.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.6
Altman-Z N/A
ROIC/WACCN/A
WACC16.33%
NBHC Yearly LT Debt VS Equity VS FCFNBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
NBHC Yearly Current Assets VS Current LiabilitesNBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

NBHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.93%.
NBHC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.78% yearly.
Looking at the last year, NBHC shows a decrease in Revenue. The Revenue has decreased by -2.66% in the last year.
Measured over the past years, NBHC shows a small growth in Revenue. The Revenue has been growing by 7.10% on average per year.
EPS 1Y (TTM)-12.93%
EPS 3Y2.5%
EPS 5Y4.78%
EPS Q2Q%-23.17%
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y10.98%
Revenue growth 5Y7.1%
Sales Q2Q%-1.3%

3.2 Future

Based on estimates for the next years, NBHC will show a small growth in Earnings Per Share. The EPS will grow by 1.64% on average per year.
Based on estimates for the next years, NBHC will show a small growth in Revenue. The Revenue will grow by 6.01% on average per year.
EPS Next Y-5.53%
EPS Next 2Y1.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.07%
Revenue Next 2Y6.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NBHC Yearly Revenue VS EstimatesNBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
NBHC Yearly EPS VS EstimatesNBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.21, which indicates a correct valuation of NBHC.
The rest of the industry has a similar Price/Earnings ratio as NBHC.
NBHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 12.03, which indicates a correct valuation of NBHC.
NBHC's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. NBHC is more expensive than 65.48% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, NBHC is valued rather cheaply.
Industry RankSector Rank
PE 13.21
Fwd PE 12.03
NBHC Price Earnings VS Forward Price EarningsNBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

NBHC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 12.13
EV/EBITDA N/A
NBHC Per share dataNBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.77
EPS Next 2Y1.64%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

NBHC has a Yearly Dividend Yield of 2.99%.
NBHC's Dividend Yield is comparable with the industry average which is at 3.31.
NBHC's Dividend Yield is a higher than the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.99%

5.2 History

The dividend of NBHC is nicely growing with an annual growth rate of 8.36%!
NBHC has paid a dividend for at least 10 years, which is a reliable track record.
NBHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.36%
Div Incr Years9
Div Non Decr Years12
NBHC Yearly Dividends per shareNBHC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

39.49% of the earnings are spent on dividend by NBHC. This is a low number and sustainable payout ratio.
NBHC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP39.49%
EPS Next 2Y1.64%
EPS Next 3YN/A
NBHC Yearly Income VS Free CF VS DividendNBHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M
NBHC Dividend Payout.NBHC Dividend Payout, showing the Payout Ratio.NBHC Dividend Payout.PayoutRetained Earnings

NATIONAL BANK HOLD-CL A

NYSE:NBHC (7/11/2025, 8:04:00 PM)

After market: 40.02 0 (0%)

40.02

-0.16 (-0.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-22 2025-07-22/amc
Inst Owners100.01%
Inst Owner Change0%
Ins Owners2.18%
Ins Owner Change2.68%
Market Cap1.52B
Analysts76
Price Target42.08 (5.15%)
Short Float %1.93%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 2.99%
Yearly Dividend1.13
Dividend Growth(5Y)8.36%
DP39.49%
Div Incr Years9
Div Non Decr Years12
Ex-Date05-30 2025-05-30 (0.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.63%
Min EPS beat(2)-18.19%
Max EPS beat(2)10.94%
EPS beat(4)2
Avg EPS beat(4)-1.06%
Min EPS beat(4)-18.19%
Max EPS beat(4)13.02%
EPS beat(8)5
Avg EPS beat(8)0.3%
EPS beat(12)9
Avg EPS beat(12)4.35%
EPS beat(16)12
Avg EPS beat(16)4.68%
Revenue beat(2)1
Avg Revenue beat(2)-3.23%
Min Revenue beat(2)-6.88%
Max Revenue beat(2)0.42%
Revenue beat(4)2
Avg Revenue beat(4)-2.7%
Min Revenue beat(4)-6.88%
Max Revenue beat(4)1.1%
Revenue beat(8)3
Avg Revenue beat(8)-2.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.48%
Revenue beat(16)6
Avg Revenue beat(16)-1.86%
PT rev (1m)1.6%
PT rev (3m)-14.42%
EPS NQ rev (1m)-1.47%
EPS NQ rev (3m)-0.53%
EPS NY rev (1m)-0.92%
EPS NY rev (3m)-7.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE 13.21
Fwd PE 12.03
P/S 3.75
P/FCF 12.13
P/OCF 9.24
P/B 1.15
P/tB 1.57
EV/EBITDA N/A
EPS(TTM)3.03
EY7.57%
EPS(NY)3.33
Fwd EY8.31%
FCF(TTM)3.3
FCFY8.24%
OCF(TTM)4.33
OCFY10.82%
SpS10.68
BVpS34.9
TBVpS25.43
PEG (NY)N/A
PEG (5Y)2.77
Profitability
Industry RankSector Rank
ROA 1.1%
ROE 8.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 27.33%
GM N/A
FCFM 30.88%
ROA(3y)1.13%
ROA(5y)1.2%
ROE(3y)9.09%
ROE(5y)9.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-2.49%
PM growth 5Y0.93%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.6
Debt/EBITDA N/A
Cap/Depr 160.32%
Cap/Sales 9.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 113%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC16.33%
ROIC/WACCN/A
Cap/Depr(3y)124.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.96%
Cap/Sales(5y)N/A
Profit Quality(3y)159.33%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.93%
EPS 3Y2.5%
EPS 5Y4.78%
EPS Q2Q%-23.17%
EPS Next Y-5.53%
EPS Next 2Y1.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y10.98%
Revenue growth 5Y7.1%
Sales Q2Q%-1.3%
Revenue Next Year5.07%
Revenue Next 2Y6.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.75%
FCF growth 3Y-12.4%
FCF growth 5Y29.61%
OCF growth 1Y12.2%
OCF growth 3Y-4.72%
OCF growth 5Y28.57%